{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:34:45Z","timestamp":1792586085291,"version":"4.5.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Drug use disorders (DUDs) represent a major global health challenge, leading to substantial morbidity and mortality, while also being compounded by social and structural barriers. In this study, we examined global epidemiological trends in DUDs over the past three decades to inform clinical and public health responses. We extracted data on the incidence, deaths, and disability-adjusted life years (DALYs) attributable to DUDs from the 2021 Global Burden of Diseases, Injuries, and Risk Factors Study between 1990 and 2021. Age-standardized incidence (ASIR), mortality (ASMR), and DALY rates per 100,000 population were calculated. The analysis focused on four DUDs\u2014opioid, amphetamine, cocaine, and cannabis use disorders\u2014and further stratified rates by sex, Socio-demographic Index (SDI), countries, and world regions. In 2021, there were 13.6 (95% UI, 11.6\u201315.7) million new cases, 137,278 (95% UI, 129,269\u2013146,181) deaths, and 15.6 (95% UI, 12.8\u201318.1) million DALYs attributed to DUDs. Between 1990 and 2021, the ASIR decreased by 8.1%, while the ASMR and DALY rates rose by 30.8% and 14.8%, respectively. Opioid use disorder accounted for the highest ASIR (169.4 [95% UI, 145.1\u2013195.0] per 100,000), ASMR (1.7 [95% UI, 1.6\u20131.8] per 100,000), and age-standardized DALY rate (191.0 [95% UI, 156.1\u2013222.8] per 100,000) in 2021. Sex and geographical variations were notable, with males and world regions like high-income North America, Australasia, and Eastern\/Western Europe showing disproportionately higher rates. Overall, these findings highlight rising mortality and morbidity rates despite a modest decline in incidence, underscoring the need for tailored public health interventions, advancing harm reduction programs, and expanding access to treatment.<\/jats:p>","DOI":"10.1371\/journal.pone.0328276","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:46:32Z","timestamp":1755798392000},"page":"e0328276","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Global burden of disease due to opioid, amphetamine, cocaine, and cannabis use disorders, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0173-495X","authenticated-orcid":true,"given":"David T.","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4556-1931","authenticated-orcid":true,"given":"Ye In Christopher","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4984-999X","authenticated-orcid":true,"given":"Alan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Min\u2013Gi","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek A.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"pone.0328276.ref001","doi-asserted-by":"crossref","first-page":"103677","DOI":"10.1016\/j.ajp.2023.103677","article-title":"Prevalence, incidence, deaths, and disability-adjusted life-years of drug use disorders for 204 countries and territories during the past 30 years","volume":"86","author":"J Shen","year":"2023","journal-title":"Asian J Psychiatr"},{"key":"pone.0328276.ref002","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaa432","article-title":"Infectious Diseases and Injection Drug Use: Public Health Burden and Response","volume":"222","author":"A Levitt","year":"2020","journal-title":"J Infect Dis"},{"key":"pone.0328276.ref003","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2004.08.003","article-title":"Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies","volume":"76","author":"HC Wilcox","year":"2004","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"pone.0328276.ref004","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1176\/appi.ajp.160.5.890","article-title":"The role of psychiatric disorders in predicting drug dependence treatment outcomes","volume":"160","author":"WM 3rd Compton","year":"2003","journal-title":"Am J Psychiatry"},{"key":"pone.0328276.ref005","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: A systematic analysis for the global burden of disease study 2019","volume":"396","author":"T Vos","year":"2020","journal-title":"The Lancet"},{"issue":"9904","key":"pone.0328276.ref006","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(13)61530-5","article-title":"Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010","volume":"382","author":"L Degenhardt","year":"2013","journal-title":"Lancet"},{"key":"pone.0328276.ref007","unstructured":"World Drug Report 2023. United Nations: Office on Drugs and Crime. (accessed Sept 7, 2024). https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2023.html"},{"issue":"2","key":"pone.0328276.ref008","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1176\/appi.ajp.2021.21040381","article-title":"Surging Racial Disparities in the U.S. Overdose Crisis","volume":"179","author":"J Friedman","year":"2022","journal-title":"Am J Psychiatry"},{"key":"pone.0328276.ref009","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/add.16318","article-title":"Charting the fourth wave: Geographic, temporal, race\/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010\u20132021","volume":"118","author":"J Friedman","year":"2023","journal-title":"Addiction"},{"key":"pone.0328276.ref010","doi-asserted-by":"crossref","first-page":"209484","DOI":"10.1016\/j.josat.2024.209484","article-title":"A scoping review of social determinants of health\u2019s impact on substance use disorders over the life course","volume":"166","author":"C Lin","year":"2024","journal-title":"J Subst Use Addict Treat"},{"issue":"2","key":"pone.0328276.ref011","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2105\/AJPH.2019.305412","article-title":"Polysubstance Use: A Broader Understanding of Substance Use During the Opioid Crisis","volume":"110","author":"TJ Cicero","year":"2020","journal-title":"Am J Public Health"},{"key":"pone.0328276.ref012","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","author":"M Naghavi","year":"2024","journal-title":"The Lancet"},{"issue":"5","key":"pone.0328276.ref013","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/add.14474","article-title":"Illicit fentanyls in the opioid street market: desired or imposed?","volume":"114","author":"SG Mars","year":"2019","journal-title":"Addiction"},{"key":"pone.0328276.ref014","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","article-title":"Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review","volume":"134","author":"P Armenian","year":"2018","journal-title":"Neuropharmacology"},{"issue":"5","key":"pone.0328276.ref015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.13861","article-title":"Evaluation of Strategies to Enhance Community-Based Naloxone Distribution Supported by an Opioid Settlement","volume":"7","author":"X Zang","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"2","key":"pone.0328276.ref016","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1001\/jamapsychiatry.2018.3126","article-title":"Prevention and Treatment of Opioid Misuse and Addiction: A Review","volume":"76","author":"ND Volkow","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"pone.0328276.ref017","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1747-597X-6-3","article-title":"Treatment utilization and barriers to treatment: results of a survey of dependent methamphetamine users","volume":"6","author":"P Kenny","year":"2011","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"6","key":"pone.0328276.ref018","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1111\/add.15783","article-title":"Did the under-reporting of meth\/amphetamine use increase in a general population survey in Australia as negative media coverage increased?","volume":"117","author":"GCK Chan","year":"2022","journal-title":"Addiction"},{"key":"pone.0328276.ref019","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.drugpo.2016.06.001","article-title":"The stigmatisation of \u201cice\u201d and under-reporting of meth\/amphetamine use in general population surveys: A case study from Australia","volume":"36","author":"J Chalmers","year":"2016","journal-title":"Int J Drug Policy"},{"issue":"6","key":"pone.0328276.ref020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.9740\/mhc.2021.11.347","article-title":"Pharmacotherapy treatment of stimulant use disorder","volume":"11","author":"MT Liu","year":"2021","journal-title":"Ment Health Clin"},{"key":"pone.0328276.ref021","doi-asserted-by":"crossref","first-page":"512076","DOI":"10.3389\/fpsyt.2021.512076","article-title":"Psychosocial Interventions for Amphetamine Type Stimulant Use Disorder: An Overview of Systematic Reviews","volume":"12","author":"MTN Tran","year":"2021","journal-title":"Front Psychiatry"},{"issue":"10209","key":"pone.0328276.ref022","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/S0140-6736(19)32230-5","article-title":"Responding to global stimulant use: challenges and opportunities","volume":"394","author":"M Farrell","year":"2019","journal-title":"Lancet"},{"key":"pone.0328276.ref023","doi-asserted-by":"crossref","first-page":"108148","DOI":"10.1016\/j.drugalcdep.2020.108148","article-title":"Cocaine use and overdose mortality in the United States: Evidence from two national data sources, 2002-2018","volume":"214","author":"M Cano","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"pone.0328276.ref024","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/add.14878","article-title":"The rise in non-fatal and fatal overdoses involving stimulants with and without opioids in the United States","volume":"115","author":"B Hoots","year":"2020","journal-title":"Addiction"},{"issue":"6","key":"pone.0328276.ref025","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMc2015435","article-title":"Evaluation of an Unsanctioned Safe Consumption Site in the United States","volume":"383","author":"AH Kral","year":"2020","journal-title":"N Engl J Med"},{"key":"pone.0328276.ref026","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12954-015-0082-x","article-title":"Public opinion and medical cannabis policies: examining the role of underlying beliefs and national medical cannabis policies","volume":"12","author":"SR Sznitman","year":"2015","journal-title":"Harm Reduct J"},{"issue":"6","key":"pone.0328276.ref027","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jamapsychiatry.2017.0724","article-title":"US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991-1992 to 2012-2013","volume":"74","author":"DS Hasin","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"pone.0328276.ref028","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00213-021-06047-8","article-title":"Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada","volume":"239","author":"J Leung","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"pone.0328276.ref029","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/dar.13578","article-title":"Trends in cannabis use intention around the period of cannabis legalisation in Australia: An age-period-cohort model","volume":"42","author":"V Chiu","year":"2023","journal-title":"Drug Alcohol Rev"},{"issue":"4","key":"pone.0328276.ref030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/YCO.0000000000000332","article-title":"Substance use and addictive disorders in DSM-5 and ICD 10 and the draft ICD 11","volume":"30","author":"JB Saunders","year":"2017","journal-title":"Curr Opin Psychiatry"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0328276","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:46:37Z","timestamp":1755798397000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0328276"}},"subtitle":[],"editor":[{"given":"Kimberly","family":"Page","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0328276","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]}}}